Cannabidiol-type cannabinoid compound
AssigneeGW Research Limited
InventorsGeoffrey Guy, Volker Knappertz, Benjamin Whalley, Marie Woolley-Roberts
Life of this patent
Estimating the term…
Abstract
The present invention relates to a cannabidiol (CBD) type cannabinoid compound for use as a medicament. The CBD-type cannabinoid, 6-hydroxy cannabidivarin (6-OH CBDV), is a metabolite of cannabidivarin (CBDV). The cannabinoid can be produced by synthetic means and a method for the production of 6-OH CBDV is described herein. In addition, disclosed herein are data which demonstrate the efficacy of 6-OH CBDV in a model of disease.
Claims20
A method of treating epilepsy in a subject in need thereof, comprising administering a therapeutically effective dose of 6-hydroxy cannabidivarin (6-OH CBDV) to the subject.
Dependencies are inferred from the claim text.